The development and production of sterile injectable medicines is one of the core competencies of leading Indian pharmaceutical manufacturer Zydus Cadila, headquartered in Ahmedabad. Vaccines, gastro-intestinal and cardiovascular drugs as well as anti-infectives and therapies for respiratory diseases are central pillars of the company’s portfolio.
Ever since its extensive restructuring in the mid-1990s, Zydus Cadila has grown dramatically. The company reports sales of more than US$1bn annually and currently employs about 13,000 staff on four continents. Eight production sites in India, the US, Brazil, South Africa, Spain, France and Japan serve customers around the globe. Between 2009 and 2010 alone, the company launched 14 new products – including eight generics.
At the end of 2011, Zydus Cadila decided to increase its production capacities for pharmaceutical liquids by investing in new equipment. Romaco’s Macofar VF 18 aseptic liquid filler was chosen to meet this challenge. The machine was shipped within six months of the order being placed and installed at Zydus Cadila’s headquarters in Ahmedabad in May 2012. It has been operating in three shifts ever since, filling sterile injectables into vials.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.